North Little Rock, Arkansas Clinical Trials

A listing of North Little Rock, Arkansas clinical trials actively recruiting patient volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 145 clinical trials
EMPACT-MI: A Study to Test Whether Empagliflozin Can Lower the Risk of Heart Failure and Death in People Who Had a Heart Attack (Myocardial Infarction)

This is a study in adults who had a heart attack (myocardial infarction). The purpose of this study is to find out whether a medicine called empagliflozin helps to lower the chances of having to go to the hospital for heart failure and whether it lowers the chances of dying …

stemi
cardiovascular disease
acute myocardial infarction
st elevation myocardial infarction
angiography
Arkansas Cardiology, PA
 (5.1 away) Contact site
  • 0 views
  • 23 Jun, 2021
  • +84 other locations
A Study of Talquetamab in Participants With Relapsed or Refractory Multiple Myeloma

The purpose of this study is to evaluate the efficacy of talquetamab in participants with relapsed or refractory multiple myeloma at the recommended Phase 2 dose (RP2D) (Part 3).

measurable disease
multiple myeloma
University of Arkansas for Medical Sciences
 (4.6 away) Contact site
  • 0 views
  • 23 Jun, 2021
  • +75 other locations
Anticoagulation in ICH Survivors for Stroke Prevention and Recovery

Primary Aim: To determine if apixaban is superior to aspirin for prevention of the composite outcome of any stroke (hemorrhagic or ischemic) or death from any cause in patients with recent ICH and atrial fibrillation (AF). Secondary Aim: To determine if apixaban, compared with aspirin, results in better functional outcomes …

fibrillation
electrocardiogram
vascular disease
apixaban
antiplatelet agents
UAMS Medical Center
 (5.1 away) Contact site
  • 84 views
  • 19 Jun, 2021
  • +101 other locations
TAK-018 for Prevention of the Recurrence of Postoperative Crohn's Disease (CD)

The purpose of this study is to evaluate the efficacy of TAK-018 in reducing endoscopic recurrence of intestinal inflammation in postoperative participants with CD after a planned laparoscopic ileocecal resection with primary anastomosis.

crohn's disease
tumor necrosis factor
antibiotics
antibiotic therapy
tumour necrosis
University of Arkansas for Medical Sciences
 (5.1 away) Contact site
  • 10 views
  • 21 Jun, 2021
  • +62 other locations
A Long-term Extension Study of Apremilast (CC-10004) in Pediatric Subjects From 6 Through 17 Years of Age With Moderate to Severe Plaque Psoriasis

This study was created to provide subjects who complete Week 52 (end of Apremilast Extension Phase) of study CC-10004-PPSO-003 the option to continue to receive open-label apremilast therapy. The study will consist of up to 208 weeks of long-term treatment followed by an 8-week observational follow-up phase.

cervical cap
tubal ligation
apremilast
plaque psoriasis
hormonal contraception
Research Site
 (4.6 away) Contact site
  • 0 views
  • 15 Jun, 2021
  • +62 other locations
A 12-Month Study of Lasmiditan (LY573144) Treatment in Children Aged 6 to 17 With Migraine

The reason for this 12-month, open-label study is to see if the study drug lasmiditan is safe and effective for the intermittent acute treatment of migraine in children aged 6 to 17. The study will last about 12 months and may include up to 7 visits.

lasmiditan
migraine in children
ly573144
acute treatment
University of Arkansas for Medical Sciences
 (2.9 away) Contact site
  • 129 views
  • 23 Jun, 2021
  • +236 other locations
Long-term Safety and Efficacy Study of Lebrikizumab (LY3650150) in Participants With Moderate-to-Severe Atopic Dermatitis (ADjoin)

This 110-week study is designed to assess the long-term safety and efficacy of lebrikizumab for moderate-to-severe atopic dermatitis.

progestogen
atopy
lebrikizumab
eczema
hormonal contraception
Arkansas Skin Cancer Center - Little Rock
 (5.1 away) Contact site
  • 154 views
  • 23 Jun, 2021
  • +344 other locations
Study of Efficacy and Safety of Ligelizumab in Chronic Spontaneous Urticaria Patients Who Completed a Previous Study With Ligelizumab

The purpose of this extension study is to establish efficacy and safety of ligelizumab. This will be assessed in adult and adolescent chronic spontaneous urticaria (CSU) patients who have completed a preceding ligelizumab study and have relapsed, following treatment in these preceding studies, despite standard of care H1-antihistamine (H1-AH) treatment. …

antihistamines
urticaria
ligelizumab
Novartis Investigative Site
 (2.3 away) Contact site
  • 0 views
  • 15 Jun, 2021
  • +215 other locations
A Phase 3 Trial of Pamrevlumab or Placebo in Combination With Systemic Corticosteroids in Subjects With Non-ambulatory Duchenne Muscular Dystrophy (DMD)

To evaluate the efficacy and safety of pamrevlumab versus placebo in combination with systemic corticosteroids in subjects with non-ambulatory Duchenne muscular dystrophy (age 12 years and older).

total bilirubin
duchenne muscular dystrophy
drug test
cardiomyopathy
prednisolone
Arkansas Children's
 (2.9 away) Contact site
  • 60 views
  • 21 Jun, 2021
  • +29 other locations
A Study of Lasmiditan (LY573144) Treatment in Children Aged 6 to 17 With Migraine

The reason for this study is to see if lasmiditan is safe and effective in children aged 6 to 17 with migraine. The study will last up to 20 weeks and may include up to 4 visits.

lasmiditan
preventive medication
ly573144
headache
University of Arkansas for Medical Sciences
 (2.9 away) Contact site
  • 122 views
  • 23 Jun, 2021
  • +236 other locations